Not 3 weeks after taking Humacyte public, Rajiv Shukla launches another blank check company
One of biotech’s earliest SPAC investors is back with another blank check company, less than a month after his last effort announced its intent to …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
